CH617927A5 - - Google Patents

Download PDF

Info

Publication number
CH617927A5
CH617927A5 CH460679A CH460679A CH617927A5 CH 617927 A5 CH617927 A5 CH 617927A5 CH 460679 A CH460679 A CH 460679A CH 460679 A CH460679 A CH 460679A CH 617927 A5 CH617927 A5 CH 617927A5
Authority
CH
Switzerland
Prior art keywords
group
derivatives
oxyphenylbutazone
bis
general formula
Prior art date
Application number
CH460679A
Other languages
German (de)
English (en)
Inventor
Dieter Rahtz
Henning Koch
Erich Gerhards
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of CH617927A5 publication Critical patent/CH617927A5/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C243/00Compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/28Two oxygen or sulfur atoms
    • C07D231/30Two oxygen or sulfur atoms attached in positions 3 and 5
    • C07D231/32Oxygen atoms
    • C07D231/34Oxygen atoms with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached in position 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
CH460679A 1974-07-29 1979-05-17 CH617927A5 (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2436882A DE2436882A1 (de) 1974-07-29 1974-07-29 Neue oxyphenylbutazon-derivate und ihre herstellung

Publications (1)

Publication Number Publication Date
CH617927A5 true CH617927A5 (ja) 1980-06-30

Family

ID=5922046

Family Applications (2)

Application Number Title Priority Date Filing Date
CH989675A CH617926A5 (ja) 1974-07-29 1975-07-29
CH460679A CH617927A5 (ja) 1974-07-29 1979-05-17

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CH989675A CH617926A5 (ja) 1974-07-29 1975-07-29

Country Status (20)

Country Link
US (1) US3968219A (ja)
JP (1) JPS5136452A (ja)
AT (1) AT344689B (ja)
AU (1) AU8332175A (ja)
BE (1) BE831855A (ja)
CA (1) CA1062264A (ja)
CH (2) CH617926A5 (ja)
CS (1) CS197252B2 (ja)
DD (1) DD122533A5 (ja)
DE (1) DE2436882A1 (ja)
DK (1) DK137009C (ja)
ES (1) ES439810A1 (ja)
FR (1) FR2280374A1 (ja)
GB (1) GB1519498A (ja)
HU (1) HU170518B (ja)
IE (1) IE41639B1 (ja)
IL (1) IL47768A (ja)
NL (1) NL7509060A (ja)
SE (1) SE415252B (ja)
SU (1) SU593662A3 (ja)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9915184D0 (en) * 1999-06-29 1999-09-01 Viral As A Compounds
IL142037A0 (en) * 2001-03-15 2002-03-10 Agis Ind 1983 Ltd Pharmaceutical compositions containing a non-steroidal anti-inflammatory drug
US20080262068A1 (en) * 2004-05-12 2008-10-23 A-Viral Asa Method of Tonic Treatment With Oxyphenbutazone Derivatives
US8729108B2 (en) * 2008-06-17 2014-05-20 Christopher J Dannaker Waterborne topical compositions for the delivery of active ingredients such as azelaic acid
AU2011231543B2 (en) 2010-03-26 2015-01-15 Galderma Research & Development Improved methods and compositions for safe and effective treatment of erythema
US9744168B2 (en) 2011-10-19 2017-08-29 Galderma Laboratories, Inc. Method of reducing facial flushing associated with systemic use of phosphodiesterase type 5 inhibitors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR5404M (ja) * 1965-09-08 1967-09-25
FR2054447B1 (ja) * 1969-07-03 1973-06-08 Synthelabo

Also Published As

Publication number Publication date
CA1062264A (en) 1979-09-11
AT344689B (de) 1978-08-10
BE831855A (fr) 1976-01-29
DE2436882A1 (de) 1976-02-19
GB1519498A (en) 1978-07-26
IL47768A (en) 1979-10-31
IL47768A0 (en) 1975-10-15
FR2280374B1 (ja) 1980-04-30
DK137009B (da) 1978-01-02
IE41639B1 (en) 1980-02-13
FR2280374A1 (fr) 1976-02-27
SE7508543L (sv) 1976-01-30
ATA583675A (de) 1977-12-15
US3968219A (en) 1976-07-06
ES439810A1 (es) 1977-04-16
SE415252B (sv) 1980-09-22
CH617926A5 (ja) 1980-06-30
DK137009C (da) 1978-05-22
DK344375A (da) 1976-01-30
DD122533A5 (ja) 1976-10-12
JPS5136452A (ja) 1976-03-27
IE41639L (en) 1976-01-29
SU593662A3 (ru) 1978-02-15
AU8332175A (en) 1977-01-27
HU170518B (ja) 1977-06-28
NL7509060A (nl) 1976-02-02
CS197252B2 (en) 1980-04-30

Similar Documents

Publication Publication Date Title
DD158773A5 (de) Verfahren zur herstellung neuer glycerol-deri vate
DE2618609C2 (de) 3-Fluor- und 3-Cyano-4-alkoxybenzoesäure-4'-alkylphenylester mit starker negativer dielektrischer Anisotropie sowie diese Verbindungen enthaltende mesomorphe Gemische für elektrooptische Zwecke
DE3536669A1 (de) Zusammensetzung fuer die perkutane verabreichung von medikamenten und verfahren zur foerderung der perkutanen absorption von medikamenten
DE2751301A1 (de) Glucofuranose-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
CH615924A5 (ja)
DE2812164A1 (de) Verwendung von wirkstoffvorlaeufern bei der bekaempfung bzw. behandlung von proliferativen hauterkrankungen
DE1801750A1 (de) Von Prostaglandinen abgeleitete Verbindungen und Verfahren zu ihrer Herstellung
CH617927A5 (ja)
DE2948733A1 (de) Steroidspirothiazolidinderivate, verfahren zur herstellung derselben und diese enhaltende arzneimittel
DE4229050A1 (de) Neue 9-Chlor-Prostaglandin-Ester und -amide
EP0656889B1 (de) 9-chlor-prostaglandin-ester und -amide und ihre verwendung für die herstellung von arzneimitteln
WO1990009373A1 (de) Hydroxyalkancarbonsäure-derivate, deren herstellung und verwendung
CH638510A5 (de) Prostacyclinanaloga.
CH634083A5 (de) Verfahren zur herstellung neuer kortikoide.
DE69606364T2 (de) Prostaglandinderivate
DE1938218C3 (de) 9 a,21,21-Trichlor-ll ß-fluor- pregnene, Verfahren zu deren Herstellung sowie diese enthaltende Arzneimittel
EP0009776A1 (de) N-Monohydroxypropylamide, N-Dihydroxypropylamide und deren Acetonoide der all-E- und 13-Z-Retinsäure, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Mittel
DE69705238T2 (de) Derivate der asiatica-saeure mit einem modifizierten a-ring
CH632772A5 (en) Process for preparing novel derivatives of 9-chloroprednisolone
DE2703543C2 (de) 2l-(3-Benzoylpropionyloxy)-11β,17α-dihydroxy-1,4-pregnadien-3,20-dion, Verfahren zu seiner Herstellung und diese Verbindung enthaltende pharmazeutische Präparate
DE2500599A1 (de) Vincamin-2-ketoglutarat und verfahren zu seiner herstellung
CH526527A (de) Verfahren zur Herstellung eines neuen 6a-Methyl-19-nor-progesterons
DE1668809B2 (de) Prostaglandinverbindungen, Verfahren zu deren Herstellung und sie enthaltende therapeutische Mittel
DE4229048A1 (de) Ester von 9-Chlor-Prostaglandinen, Verfahren zu ihrer Herstellung und ihre pharmazeutische Verwendung
AT319493B (de) Verfahren zur Herstellung von neuen 21-Halogensteroiden

Legal Events

Date Code Title Description
PL Patent ceased